HGH Therapy
Human Growth Hormone (HGH) therapy involves the administration of recombinant human growth hormone, a bioidentical 191-amino acid protein identical to the GH produced by the anterior pituitary gland. With decades of clinical use and FDA-approved indications for adult GH deficiency, HGH therapy represents the most direct approach to addressing growth hormone decline.
Direct Growth Hormone Replacement for Documented Deficiency
Human Growth Hormone (HGH) therapy utilizes recombinant DNA technology to produce a 191 amino acid protein that is structurally identical to the growth hormone naturally secreted by the anterior pituitary gland. First synthesized using recombinant methods in the 1980s (replacing earlier cadaveric pituitary extracts), rhGH has become one of the most extensively studied hormones in medicine, with FDA-approved indications for both pediatric and adult growth hormone deficiency (AGHD).
In adults, growth hormone plays essential roles in body composition maintenance, metabolic regulation, bone density, cardiovascular health, cognitive function, and overall vitality. The natural decline in GH production that begins around age 30 - progressing at approximately 14% per decade - leads to a state termed somatopause. Clinical research has established that adults with documented GH deficiency experience measurable deterioration in body composition (increased visceral adiposity, decreased lean mass), bone mineral density, lipid profiles, cardiovascular function, and quality of life metrics. FDA approval for adult GH replacement is based on extensive clinical trial evidence demonstrating improvement across these parameters.
Aspire Rejuvenation provides physician-supervised HGH therapy for patients with documented growth hormone deficiency or insufficiency. All protocols begin with comprehensive diagnostic testing, including GH stimulation testing when appropriate, to establish medical necessity. Our physicians prescribe FDA-approved rhGH products from licensed pharmacies, ensuring pharmaceutical-grade quality and regulatory compliance.
Proposed Mechanism of Action
Growth hormone exerts its effects through two primary pathways: direct tissue action and indirect effects mediated by IGF-1. Direct GH effects involve binding to the growth hormone receptor (GHR), a transmembrane receptor that activates the JAK2-STAT5 signaling pathway upon dimerization. In adipose tissue, this direct pathway is responsible for GH's powerful lipolytic effect - it activates hormone-sensitive lipase and suppresses lipoprotein lipase, promoting fat mobilization from adipose stores. This is why GH's fat-reducing effects are observed even before significant IGF-1 elevation occurs. In the liver, GH receptor activation drives the synthesis and secretion of IGF-1, which then circulates bound to IGF-binding proteins (primarily IGFBP-3 and the acid-labile subunit).
IGF-1 mediates many of GH's growth-promoting and anabolic effects through its own receptor (IGF-1R), a tyrosine kinase receptor that activates PI3K/Akt and MAPK/ERK pathways. These cascades promote protein synthesis, cell proliferation, and cell survival in muscle, bone, cartilage, and other tissues. The GH-IGF-1 axis is regulated by negative feedback: IGF-1 suppresses pituitary GH release and hypothalamic GHRH secretion. This feedback mechanism is important to understand in the context of exogenous GH therapy, as administered rhGH will suppress the pituitary's own GH production during treatment. Clinical dosing is calibrated to achieve physiological IGF-1 levels that support optimal function without exceeding the normal range.
What HGH Therapy Is Being Explored For
These are the primary areas where HGH Therapy has been studied or discussed in the context of peptide therapy. Research depth varies by area.
How HGH Therapy Is Offered
HGH Therapy is available through Aspire in the following formulations, all compounded by licensed U.S. 503A pharmacies. Your clinician will recommend the appropriate form based on your goals and treatment plan.
How Treatment Works
Peptide therapy at Aspire follows a clinician-guided process. HGH Therapy is not available for self-prescribing or anonymous purchase.
HGH Therapy FAQ
HGH therapy for adult growth hormone deficiency is supported by extensive clinical trial evidence and carries FDA approval. It represents one of the most thoroughly studied hormone replacement therapies in medicine, with well-established efficacy and safety profiles from decades of clinical use.
Ready to explore HGH Therapy?
Talk with an Aspire clinician about your goals and whether HGH Therapy therapy may be appropriate for you.
Text Us Now
